(FHLC) Fidelity MSCI Health Care - Overview

ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 2.989m USD | Total Return: 13.9% in 12m

Pharmaceuticals, Medical Devices, Biotechnology, Healthcare Services
Total Rating 37
Safety 57
Buy Signal -0.14
Health
Category Rotation: +3.9
TER: 0.08%
AUM: 2.99B
Avg Turnover: 11.8M
Risk 3d forecast
Volatility15.2%
VaR 5th Pctl2.72%
VaR vs Median-0.86%
Reward TTM
Sharpe Ratio0.68
Rel. Str. IBD27.1
Rel. Str. Peer Group50
Character TTM
Beta0.410
Beta Downside0.463
Hurst Exponent0.490
Drawdowns 3y
Max DD16.87%
CAGR/Max DD0.36
CAGR/Mean DD1.16

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: FHLC Fidelity MSCI Health Care

The Fidelity MSCI Health Care Index ETF (FHLC) seeks to track the performance of the MSCI USA IMI Health Care 25/50 Index by investing at least 80% of its assets in constituent securities. This index captures the U.S. health care sector across large, mid, and small-cap segments, utilizing a capped weighting strategy to prevent individual holdings from dominating the portfolio. As a non-diversified fund, it maintains concentrated exposure to industries including pharmaceuticals, biotechnology, and healthcare equipment.

The health care sector is characterized by high research and development (R&D) costs and extensive regulatory oversight by the FDA. Business models in this space often rely on patent protections to maintain profit margins before generic competition enters the market. Investors can use ValueRay to further analyze the fundamental metrics of these underlying holdings. The demand for these services is largely driven by demographic shifts, such as an aging global population requiring increased medical intervention.

Headlines to Watch Out For
  • Pharmaceutical drug pricing legislation impacts profit margins for major index holdings
  • Medicare reimbursement rate changes dictate revenue stability for healthcare provider components
  • Research and development breakthroughs in biotechnology drive speculative capital appreciation
  • Federal Reserve interest rate policy influences valuations of growth-oriented healthcare stocks
  • Regulatory approval cycles for medical devices determine long-term revenue growth trajectories
What is the price of FHLC shares?

As of June 03, 2026, the stock is trading at USD 70.57 with a total of 174,356 shares traded.
Over the past week, the price has changed by -1.55%, over one month by +0.67%, over three months by -6.30% and over the past year by +13.85%.

Is FHLC a buy, sell or hold?

Fidelity MSCI Health Care has no consensus analysts rating.